Anti-inflammatory and cytotoxic cycloartanes from guayule (Parthenium argentatum)

Natural Product Communications

Volumn 3, Issue 3, 2008, Pages 413-422

  Flores Rosete, Graciela ^a   Martínez Vázquez, Mariano ^b  

^a CENTRO NACIONAL DE INVESTIGACIÓN Y DESARROLLO TECNOLÓGICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Anti cancer natural products; Anti inflammatory compounds; Cycloartanes; Parthenium argentatum; Triterpenes

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ARGENTATIN A; ARGENTATIN B; ARGENTATIN C; ARGENTATIN D; CYCLOARTANE; TANACETUM PARTHENIUM EXTRACT; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BINDING AFFINITY; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG BINDING; DRUG ISOLATION; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

PARTHENIUM ARGENTATUM;

EID: 77953973771     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0800300318     Document Type: Review

References (50)

1. Verpoorte R. (1998) Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development Drug Discovery Today, 3, 232-238.
2. Williams DH, Stone MJ, Hauck PR, Rahman SK. (1989) Why are secondary metabolites (natural products) biosynthesized? Journal of Natural Products, 5, 1189-1208.
3. Newman DJ, Cragg GM, Kingston DGI. (2003) Natural products as pharmaceuticals and sources for lead structures. In The Practice of Medicinal Chemistry, Wermuth CG. (Ed), Elsevier, 91-109.
4. Cragg GM, Newman DJ. (2005) Plants as a source of anti-cancer agents. Journal of Ethnopharmacology, 100, 72-79.
5. Argumedo-Delira R, Parra-Delgado H Ramírez-Apan T, Nieto-Camacho A, Martínez-Vázquez M. (2003) Isolation and chemical transformations of some anti-inflammatory triterpenes from Salvia mexicana L. var. minor Benth. Revista de la Sociedad Química de México, 47, 167-172.
6. Cichewitz RH, Kouzi SA. (2004) Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infections. Medicinal Research Reviews, 24, 90-114.
7. Choi CY, You HJ, Jeong HG. (2001) Nitric oxide and tumor necrosis factor-a production by oleanolic acid via nuclear factor-kB activation in macrophages. Biochemistry Biophysics Research Communications, 288, 49-55.
8. Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ. (2000) Ursolic acid inhibits cyclooxygenase-2. Transcription in human mammary epithelial cells. Cancer Research, 60, 2399-2404.
9. (a) Honda T, Gribble GW, Suh N, Finlay HJ, Rounds BV, Bore L, Favaloro FG, Wang Y, Sporn MB. (2000) Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages. Journal of Medicinal Chemistry, 43, 1866-1877;
10. (b) Honda T, Rounds BV, Bore L, Finlay HJ, Favaloro FG, Suh N, Wang Y, Sporn MB, Gribble GW. (2000) Novel synthetic oleanane and ursane triterpenoids with modified rings A and C: A series of highly active inhibitors of nitric oxide production in mouse macrophages. Journal of Medicinal Chemistry, 43, 4233-4246.
11. Suh N, Wang Y, Gribble GW, Dmitrovsky E, Hickey WF, Maue RA, Place AE, Porter DM, Spinella MJ, Williams CR, Wu G, Dannenberg AJ, Flanders KC, Letterio JJ, Mangelsdorf DJ, Nathan CF, Nguyen L, Porter WW, Ren RF, Roberts AB, Roche NS, Subbaramaiah K, Sporn MB. (1999) A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolen-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Research, 59, 336-341.
12. Dvorak HF. (1986) Tumors: wounds that not heal. Similarities between tumor stroma generation and wound healing. New England Journal of Medicine, 315, 1650-1659.
13. Maeda H, Akaike T. (1998) Nitric oxide and oxygen radicals in infection, inflammation and cancer. Biochemistry, 63, 854-865. (Pubitemid 128588115)
14. Pollard JW. (2004) Tumour-educated macrophages promote tumour progression and metastasis. Natural Review Cancer, 4, 71-78.
15. García-Argaez AN, Ramírez-Apan T, Parra-Delgado H, Velásquez G, Martínez-Vázquez M. (2000) Anti-inflammatory activity of coumarins from Decatropis bicolor on TPA ear mice model. Planta Medica, 66, 279-281.
16. Martínez-Vázquez M, de la Cueva LDG, Estrada-Reyes R, González Lugo NM, Ramírez-Apan T, Heinze G. (2005) Bio-guided isolation of the cytotoxic corytenchine and isocoreximine from roots of Annona cherimolia. Fitoterapia, 76, 733-736.
17. Oviedo Chávez I, Ramírez Apan T, Martínez- Vázquez M. (2005) Cytotoxic activity and effect on nitric oxide production of tirucallane-type triterpenes. Journal of Pharmacy and Pharmacology, 57, 1087-1091.
18. Rodríguez-Hann L, Romo de Vivar A, Ortega A, Aguilar M, Romo J. (1970) Determinación de las estructuras de las argentatinas A, B y C del guayule. Revista Latinoamericana de Química, 1, 24-38.
19. Romo de Vivar A, Matsubara, C. (1986) Los terpenoides de Parthenium incanum. Estudio cristalográfico por rayos X de incalina y argentatina B. Revista Latinoamericana de Química, 17, 7-9.
20. Komoroski AA, Gress EC, Shockor JP, Geckle JM. (1986) Identification of guayule triterpenes by two dimensional and multipulse NMR techniques. Magnetic Resonance in Chemistry, 24, 534-543.
21. Romo de Vivar A, Martínez-Vázquez M, Matsubara C, Pérez G, Joseph-Nathan P. (1990) Triterpenes in Parthenium argentatum Phytochemistry, 29, 915-918.
22. (a) Schloman WW, Hively RA, Krishen A, Andrew MA. (1983) Guayule by product evaluation: extract characterization. Journal of Agricultural Food Chemistry, 31, 873-876;
23. (b) Schloman WW. (1988) Rubber additives derived from guayule resin. Industrial Engineering Chemistry Research, 27, 712-716.
24. Nakayama FS. (2005) Guayule future development. Industrial Crops Production, 22, 3-13.
25. Céspedes CL, Martínez-Vázquez M, Calderón JS, Salazar JR, Aranda A. (2001) Insect growth regulatory activity of some extracts and compounds from Parthenium argentatum. Zeitschritt für Naturforschung, 56c, 95-105.
26. Hernández-Ortega S, Parra Delgado H, Martínez M. (2005) Incaline (isoargentatin A) from Parthenium argentatum. Acta Crystallographica, E61, 1921-1923.
27. Martínez R, Martínez-Vázquez M, Zamorano-Macias O. (1990) Electron impact mass spectrometry of triterpenoids from guayule. Organic Mass Spectrometry, 25, 237-238.
28. Martínez-Vázquez M, Martínez R, Toscano RA. (1995) Preparation, spectral studies and X-ray crystal structures of (16S, 17R, 20S)-3-oxo-16-hydroxy-25-nor-lanostan-24-oic lactone (II) and (16S, 17R, 20S)-4,16-dihydroxy-25-nor-3,4-seco-lanostan-3,24-dioic acid dilactone (III). Journal of Chemical Crystallography, 25, 331-337.
29. Martínez R, Arellano-García MA, Martínez- Vázquez M, Gallegos J. (1993) Synthesis of carbenoxolone analogs from argentatin B. Organic Preparations and Procedures International, 25, 698-792.
30. Martínez R, Limón E, Arellano MR, Martínez M, Brito M. (1995) Synthesis of pyrazole from argentatin B. Collection of Czechoslovak Chemical Communications, 60, 612-618.
31. Tang W, Eisenbrand G. (1992) Chinese drugs of plant origin: Chemistry, Pharmacology, and use in Traditional and Modern Medicine, Springer-Verlag.
32. Akihisa T, Yasukawa K, Oiuma H, Kasahara Y, Yamanouchi S, Takido M, Kumaki K, Tamura T. (1996) Triterpene alcohols from the flowers of Compositae and their anti-inflammatory effects. Phytochemistry, 43, 1255-1260.
33. Akihisa T, Yasukawa K. (2001) Anti-tumor-promoting and anti-inflammatory activities of triterpenoids and sterols from plants and fungi. In Studies of Natural Products Chemistry. Atta-ur-Rahman (Ed.), 25, 43-87.
34. Calzada L, Salazar EL, Téllez J, Martínez M, Martínez R. (1995) Effect of tetracyclic triterpenes (argentatins A, B and D) on the stradiol receptor of hormone-dependent tumours of human breast. Medicine Science Research, 23, 815-816.
35. Öksüz S, Shieh HL, Pezzuto JM, Özhatay N, Cordell GA. (1993) Biologically active compounds from the Euphorbiaceae, Part 1. Triterpenoids of Euphorbia nicaeensis subsp. glareosa. Planta Medica, 59, 472-473.
36. Smith-Kielland I, Dornish JM, Malterud KE, Hvistendahl G, Romming C, Bockman OC, Kolsaker P, Stenstrom Y, Nordal A. (1996) Cytotoxic triterpenoids from the leaves of Euphorbia pulcherrima. Planta Médica, 62, 322-325.
37. Banskota AH, Tezuka Y, Kim PH, Qui TK, Saiki H, Miwa Y, Taga T, Kadota S. (1998) Cytotoxic cycloartane-type triterpenes from Combretum quadrangulare. Bioorganic & Medicinal Chemistry Letters, 8, 3519-3524.
38. Parra-Delgado H, García-Pillado F, Sordo M, Ramírez-Apan T, Martínez-Vázquez M, Ostrosky-Wegman P. (2005) Evaluation of the cytotoxic, cytostatic and genotoxicity of argentatins A and B from Parthenium argentatum Gray. Life Sciences, 77, 2855-2865.
39. Hyen BJ, Soo LY, Mo KC, Kim JA, Sool KK, Chul SH, Kim K. (1997) Intracellular Ca2+ release mediates ursolic acid induced apoptosis in human leukemic HL-60 cells. International Journal of Cancer, 73, 725-728.
40. Kim D, Baek JH, Kang C, Kim K. (2000) Apoptotic activity of ursolic acid may correlate with inhibition of initiation of DNA replication. International Journal of Cancer, 87, 629-636.
41. Wick W, Grimmel C, Wagenknecht B, Dichgans J, Weller. (1999) Betunilic acid-induced apoptosis in glioma cells: a sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. Journal of Pharmacology Experimental Therapy, 289, 1306-1312.
42. Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber K, Ma W, Georgiadis C, Laskin JD, Conney AH. (1994) Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Research, 51, 701-708.
43. Lee HY, Chung HY, Kim KH, Lee JJ, Kim KW. (1994) Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids. Journal of Cancer Research and Clinical Oncology, 120, 513-518.
44. Sohn KL, Lee HY, Chung HY, Young HS, Kim KW. (1993) Anti-angiogenic activity of triterpene acids. Cancer Letters, 94, 213-218.
45. Cha HJ, Bae SK, Lee HY, Lee OH, Sato H, Seiki M, Chae PB, Kim K. (1996) Anti-invasive activity of ursolic acid correlates with reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Research, 56, 2281-2284.
46. Mizushina Y, Lida A, Sugawara F, Sakaguchi K. (2000) Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochemical Journal, 350, 757-763.
47. Parra-Delgado H, Ramírez-Apan, Martínez-Vázquez M. (2005) Synthesis of argentatin A derivatives as growth inhibitors of human cancer cell lines in vitro. Bioorganic & Medicinal Chemistry Letters, 15, 1005-1008.
48. Fenech M. (2000) The in vitro micronucleus technique. Mutation Research, 455, 81-95.
49. Kirsch-Volders M. Elhajouji A, Cundari E, Van HP (1997) The in vitro micronucleus test: a multi-endpoint assay to detect simultaneously mitotic delay apoptosis, chromosome breakage, chromosome loss and non-disjunction. Mutation Research, 392, 19-30.
50. Parra-Delgado H, Compadre CM, Ramírez-Apan T, Muñoz-Fambuena MJ, Compadre RL, Ostrosky-Wegman, Martínez-Vázquez M. (2006) Synthesis and comparative molecular field analysis (CoMFA) of argentatina B derivatives as growth inhibitors of human cancer cell lines. Bioorganic & Medicinal Chemistry, 14, 1889-1901.